Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,154
archived clinical trials in
Osteoarthritis (OA)

Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Miami, FL
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Miami, FL
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Miami, FL
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Atlanta, GA
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Atlanta, GA
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Atlanta, GA
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Chicago, IL
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Chicago, IL
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Wichita, KA
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Bay City, MI
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Bay City, MI
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Caro, MI
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Caro, MI
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Grand Rapids, MI
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Somerset, NJ
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Somerset, NJ
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Greenville, NC
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Greenville, NC
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Charleston, SC
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Memphis, TN
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Bedford, TX
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Bedford, TX
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Cypress, TX
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Cypress, TX
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Houston, TX
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Houston, TX
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Riverton, UT
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Riverton, UT
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Norfolk, VA
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
mi
from
Elblag,
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
mi
from
Elblag,
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Costa Mesa, CA
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Waxahachie, TX
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Waxahachie, TX
Click here to add this to my saved trials
Physical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis
Physical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis
Status: Enrolling
Updated:  9/27/2017
UNC Thurston Arthritis Research Center
mi
from
Chapel Hill, NC
Physical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis
Physical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis
Status: Enrolling
Updated: 9/27/2017
UNC Thurston Arthritis Research Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Walking Aids in the Management of Knee Osteoarthritis
Walking Aids in the Management of Obesity-Related Knee Osteoarthritis
Status: Enrolling
Updated:  9/29/2017
VA Greater Los Angeles Healthcare System, West LA
mi
from
West Los Angeles, CA
Walking Aids in the Management of Knee Osteoarthritis
Walking Aids in the Management of Obesity-Related Knee Osteoarthritis
Status: Enrolling
Updated: 9/29/2017
VA Greater Los Angeles Healthcare System, West LA
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Achieve Clinical Research
mi
from
Birmingham, AL
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Clinical Research Consulting, LLC
mi
from
Milford, CT
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Clinical Research Consulting, LLC
mi
from
Milford, CT
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Avail Clinical Research
mi
from
DeLand, FL
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Health Awareness
mi
from
Jupiter, FL
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Health Awareness
mi
from
Jupiter, FL
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Sunrise Medical Research
mi
from
Lauderdale Lakes, FL
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Sunrise Medical Research
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
International Clinical Research - US, LLC
mi
from
Sanford, FL
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
International Clinical Research - US, LLC
mi
from
Sanford, FL
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Miami Research Associates
mi
from
South Miami, FL
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Best Clinical Trial, LLC
mi
from
New Orleans, LA
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Best Clinical Trial, LLC
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Healthcare Research Network
mi
from
Hazelwood, MO
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Healthcare Research Network
mi
from
Hazelwood, MO
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Omega Medical Research
mi
from
Warwick, RI
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Omega Medical Research
mi
from
Warwick, RI
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Clinical Trials of South Carolina
mi
from
Charleston, SC
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Clinical Trials of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Charlottesville Medical Research Center, LLC
mi
from
Charlottesville, VA
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Charlottesville Medical Research Center, LLC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Serum and Synovium Protease Inhibitor Levels in Primary and Secondary Osteoarthritic Joints
Evaluation of Serum and Synovium Protease Inhibitor Levels in Primary and Secondary Osteoarthritic Joints, and Comparison for Patients Undergoing Joint Replacement
Status: Enrolling
Updated:  10/6/2017
Stanford University Hospital
mi
from
Palo Alto, CA
Serum and Synovium Protease Inhibitor Levels in Primary and Secondary Osteoarthritic Joints
Evaluation of Serum and Synovium Protease Inhibitor Levels in Primary and Secondary Osteoarthritic Joints, and Comparison for Patients Undergoing Joint Replacement
Status: Enrolling
Updated: 10/6/2017
Stanford University Hospital
mi
from
Palo Alto, CA
Click here to add this to my saved trials
The Effects of Group Cycling (Spinning®) With Knee Osteoarthritis: A Randomized Control Trial
The Effects of Group Cycling (Spinning®) On Gait and Pain-Related Disability in Persons With Knee Osteoarthritis: A Randomized Control Trial
Status: Enrolling
Updated:  10/13/2017
Mercy Hospital of Pittsbugh
mi
from
Pittsburgh, PA
The Effects of Group Cycling (Spinning®) With Knee Osteoarthritis: A Randomized Control Trial
The Effects of Group Cycling (Spinning®) On Gait and Pain-Related Disability in Persons With Knee Osteoarthritis: A Randomized Control Trial
Status: Enrolling
Updated: 10/13/2017
Mercy Hospital of Pittsbugh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated:  10/17/2017
Summit Orthopedics
mi
from
Woodbury, MN
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Summit Orthopedics
mi
from
Woodbury, MN
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated:  10/17/2017
Syracuse Orthopedic Specialists
mi
from
Syracuse, NY
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Syracuse Orthopedic Specialists
mi
from
Syracuse, NY
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated:  10/17/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated:  10/17/2017
Paragon Orthopedics
mi
from
Grants Pass, OR
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Paragon Orthopedics
mi
from
Grants Pass, OR
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated:  10/17/2017
OSS Health
mi
from
York, PA
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
OSS Health
mi
from
York, PA
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated:  10/17/2017
Texas Hip and Knee Center
mi
from
Fort Worth, TX
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Texas Hip and Knee Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated:  10/17/2017
NorthShore University HealthSystem-Glenbrook Hospital
mi
from
Glenview, IL
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
NorthShore University HealthSystem-Glenbrook Hospital
mi
from
Glenview, IL
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated:  10/17/2017
Sportsmed Sa
mi
from
Stepney,
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Sportsmed Sa
mi
from
Stepney,
Click here to add this to my saved trials